Medicare Enrolled
Dr. Manish Viradia, MD
Neurology · Annandale, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Viradia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Viradia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Viradia
Dr. Manish Viradia is a neurology specialist in Annandale, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Viradia performed 172,449 Medicare services across 1,888 unique beneficiaries.
Between the years covered by Open Payments, Dr. Viradia received a total of $37,698 from 94 pharmaceutical and/or device companies across 1332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Viradia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NJ
$37,698 industry payments
Medicare Practice Summary
Medicare Utilization ↗172,449
Medicare services
Top 0% in NJ for neurology
1,888
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,622 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
73,800 | $5 | $15 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
64,630 | $32 | $145 |
| Ocrelizumab infusion (Ocrevus) for MS | 18,600 | $47 | $160 |
| Injection, eptinezumab-jjmr, 1 mg | 10,400 | $13 | $32 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
1,055 | $18 | $150 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
787 | $57 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
692 | $104 | $243 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
490 | $72 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
398 | $13 | $80 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
254 | $1 | $25 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
206 | $4 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
177 | $136 | $376 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
164 | $135 | $1,000 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
118 | $86 | $475 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
116 | $57 | $400 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
103 | $121 | $994 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 73 | $69 | $202 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
59 | $189 | $700 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
53 | $26 | $584 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
51 | $86 | $315 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
42 | $175 | $850 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
34 | $143 | $450 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
31 | $120 | $600 |
| Injection, methylprednisolone acetate, 40 mg | 30 | $6 | $10 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
28 | $157 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.4% high complexity
49.6% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$37,698
Total received (2018-2024)
Avg $5,385/year across 7 years
Top 10% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
1,332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,431 (43.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,004 (39.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,263 (16.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,313
2023
$3,683
2022
$2,597
2021
$1,435
2020
$1,515
2019
$8,248
2018
$16,907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$739
Lilly USA, LLC
$215
Amneal Pharmaceuticals LLC
$203
Teva Pharmaceuticals USA, Inc.
$190
Eisai Inc.
$179
PFIZER INC.
$172
UCB, Inc.
$168
ARGENX US, INC.
$164
Biogen, Inc.
$163
Lundbeck LLC
$138
EMD Serono, Inc.
$108
Genentech USA, Inc.
$89
Novartis Pharmaceuticals Corporation
$76
Kyowa Kirin, Inc.
$72
Otsuka America Pharmaceutical, Inc.
$62
Axsome Therapeutics, Inc.
$60
SCILEX PHARMACEUTICALS INC.
$47
Alexion Pharmaceuticals, Inc.
$45
Celgene Corporation
$44
TG Therapeutics, Inc.
$41
CSL Behring
$37
ANI Pharmaceuticals, Inc.
$34
Azurity Pharmaceuticals, Inc.
$34
Neurocrine Biosciences, Inc.
$33
ACADIA Pharmaceuticals Inc
$33
Takeda Pharmaceuticals U.S.A., Inc.
$21
Boston Scientific Corporation
$20
Grifols USA, LLC
$18
SK Life Science, Inc.
$17
Amylyx Pharmaceuticals, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
Currax Pharmaceuticals LLC
$14
AstraZeneca Pharmaceuticals LP
$13
JAZZ PHARMACEUTICALS INC.
$13
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 34.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$15,115
Biogen, Inc.
$7,529
Novartis Pharmaceuticals Corporation
$1,186
ABBVIE INC.
$1,159
Teva Pharmaceuticals USA, Inc.
$1,076
AbbVie Inc.
$863
UCB, Inc.
$721
Lilly USA, LLC
$677
Supernus Pharmaceuticals, Inc.
$644
Amneal Pharmaceuticals LLC
$508
EMD Serono, Inc.
$491
Amgen Inc.
$490
Eisai Inc.
$489
Alexion Pharmaceuticals, Inc.
$342
Lundbeck LLC
$336
PFIZER INC.
$325
CSL Behring
$307
ARGENX US, INC.
$306
GENZYME CORPORATION
$299
Celgene Corporation
$247
Kyowa Kirin, Inc.
$242
Adamas Pharmaceuticals, Inc.
$207
Sunovion Pharmaceuticals Inc.
$202
Janssen Pharmaceuticals, Inc
$190
Allergan, Inc.
$187
Acorda Therapeutics, Inc
$182
SK Life Science, Inc.
$169
ARBOR PHARMACEUTICALS, INC.
$144
US WorldMeds, LLC
$141
Otsuka America Pharmaceutical, Inc.
$138
JAZZ PHARMACEUTICALS INC.
$120
LivaNova USA, Inc.
$106
Medtronic Vascular, Inc.
$105
Axsome Therapeutics, Inc.
$102
Amylyx Pharmaceuticals, Inc.
$101
ACADIA Pharmaceuticals Inc
$94
Grifols USA, LLC
$90
Mallinckrodt Hospital Products Inc.
$88
GE HEALTHCARE
$86
Bausch Health US, LLC
$86
Biohaven Pharmaceutical Holding Company Ltd.
$85
Mallinckrodt Enterprises LLC
$73
Scilex Pharmaceuticals Inc.
$71
Avanir Pharmaceuticals, Inc.
$70
Allergan Inc.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$66
EISAI INC.
$66
ANI Pharmaceuticals, Inc.
$62
Impax Laboratories, Inc.
$58
Horizon Therapeutics plc
$55
IMPEL PHARMACEUTICALS INC.
$52
Abbott Laboratories
$51
SCILEX PHARMACEUTICALS INC.
$47
Akcea Therapeutics, Inc.
$46
Boston Scientific Corporation
$43
Promius Pharma LLC
$42
AQUESTIVE THERAPEUTICS, INC.
$42
TG Therapeutics, Inc.
$41
TG THERAPEUTICS, INC.
$40
Jazz Pharmaceuticals Inc.
$40
Neurelis, Inc.
$39
Strongbridge US INC.
$39
Harmony Biosciences LLC
$37
Azurity Pharmaceuticals, Inc.
$34
Neurocrine Biosciences, Inc.
$33
GE HealthCare
$31
Alnylam Pharmaceuticals Inc.
$29
Merz Pharmaceuticals, LLC
$29
Avion Pharmaceuticals
$28
MDD US Operations, LLC
$27
Egalet US Inc
$26
Stimwave Technologies Incorporated
$25
BOSTON SCIENTIFIC CORPORATION
$21
SpineGuard, Inc.
$21
Sumitomo Pharma America, Inc.
$20
Exeltis, USA Inc.
$17
Zimmer Biomet Holdings, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
Octapharma USA, Inc.
$15
Assertio Therapeutics, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
Life Molecular Imaging Ltd
$14
Currax Pharmaceuticals LLC
$14
Daiichi Sankyo Inc.
$14
AstraZeneca Pharmaceuticals LP
$13
InSightec,Inc
$13
Sandoz Inc.
$12
Philips Electronics North America Corporation
$12
Bioventus LLC
$12
Biohaven Pharmaceuticals, Inc.
$12
Almatica Pharma LLC
$12
Aprecia Pharmaceuticals, LLC
$12
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 63.2% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · COMIRNATY · COPAXONE · DUOPA · Deep Brain Stimulation · Dhivy · Dojolvi · Durolane · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Exablate · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gel One · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · PANZYGA · PURIFIED CORTROPHIN GEL · PediGuard · Ponvory · Privigen · QELBREE · QULIPTA · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · Turalio · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · XADAGO · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIEXTENZO · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (44%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in NJ.
Geographic Context
Neurologists within 10 mi
77
Per 100K population
59.5
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
7.5 mi
7.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Viradia is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with mixed engagement industry engagement in the top 10% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Viradia experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Viradia performed 73,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Viradia receive payments from pharmaceutical companies?
Yes. Dr. Viradia received a total of $37,698 from 94 companies across 1,332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Viradia's costs compare to other neurologists in Annandale?
Dr. Viradia's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Viradia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Annandale
Browse neurologists in Annandale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology